Dr. Laura Bukavina, MD

Dr. Bukavina practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Bukavina's NPI, 1346688389, was assigned on June 12, 2013. Dr. Bukavina holds Ohio license 35.149073.

Dr. Bukavina's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Bukavina's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Bukavina is also affiliated with University Hospitals Cleveland Medical Center. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Bukavina to 4 more hospitals, 2 clinical labs and 2 medical groups, each named with a free account. Dr. Bukavina's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bukavina practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Bukavina's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Bukavina's licenses on file in 2 states: Ohio and Pennsylvania.

CMS data shows 215 Medicare services from Dr. Bukavina across 5 procedure codes in 2024, for 132 Medicare patients. Medicare paid $14,151 for them.

CMS counts 132 Medicare patients who saw Dr. Bukavina in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bukavina's median patient age at 69, with 40% women.

In 2024, Dr. Bukavina wrote 112 Medicare Part D claims for 55 patients. 92% of them were for generic drugs. CMS names the drug for 32 of them, across 1 drug with 11 or more claims each, at $239 in total drug cost. In 2021, CMS named 14 claims across 1 drug.

Dr. Bukavina accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bukavina as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 87 papers to Dr. Bukavina, published from 2018 to 2025. 2022 was the busiest year, with 15. The most frequent topics are Urinary Bladder Neoplasms, Postoperative Complications and Cystectomy. Dr. Bukavina has published most often in Urology. Dr. Bukavina's most frequent co-authors are Lee E. Ponsky, MD, Adam Christopher Calaway, MD and Megan Prunty, MD.

CMS Open Payments shows 28 general payments to Dr. Bukavina from 12 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 33% of the total. Urogen Pharma, Inc. paid the most, $3,060.